Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04156581 · ClinicalTrials.gov registry record · Phase 4
Erector Spinae Plane Block Versus Conventional Analgesia in Complex Spine Surgery
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT04156581 is a Phase 4 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 46 participants.
The verdict
NCT04156581, a Phase 4 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
Enhanced recovery pathways (ERPs) emphasize evidence-based, multimodal anesthetic and analgesic choices to minimize opioid consumption while providing adequate pain control after surgery. Although ERPs for spine surgery are now being described, few pathways include regional analgesia. The Erector Spinae Plane Block (ESPB) may represent a novel opportunity to incorporate regional analgesia into ERPs for spine surgery. To date, there is minimal data to support the utility of ESPB in spine surgery, and this block has not yet been evaluated in complex spine surgery. This study seeks to see whether ESPB will reduce opioid consumption and pain scores, and improve patient recovery during the first 24 hours after complex spine surgery when included in a comprehensive ERP.
Interventions
- DRUG Bupivacaine
- OTHER Saline
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2019-11-19 |
| Est. Completion | 2022-06-18 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04156581
The ClinicalTrials.gov registry entry for NCT04156581 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bupivacaine is the first listed.
NCT04156581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04156581 about?
NCT04156581 is a clinical study titled "Erector Spinae Plane Block Versus Conventional Analgesia in Complex Spine Surgery". Enhanced recovery pathways (ERPs) emphasize evidence-based, multimodal anesthetic and analgesic choices to minimize opioid consumption while providing adequate pain control after surgery. Although ERPs for spine surgery are now being described, few pathways include regional analgesia. The Erector Sp...
What is the current status of trial NCT04156581?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2019-11-19. Estimated completion is 2022-06-18.
What interventions are being tested in trial NCT04156581?
The interventions under investigation include: Bupivacaine (DRUG), Saline (OTHER), Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT04156581?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.